Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Operating Expenses (2021 - 2026)

HeartSciences' Operating Expenses history spans 6 years, with the latest figure at $1.9 million for Q1 2026.

  • For Q1 2026, Operating Expenses fell 18.66% year-over-year to $1.9 million; the TTM value through Jan 2026 reached $7.8 million, down 6.14%, while the annual FY2025 figure was $8.4 million, 32.24% up from the prior year.
  • Operating Expenses reached $1.9 million in Q1 2026 per HSCS's latest filing, down from $2.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $2.4 million in Q1 2025 to a low of $1.1 million in Q1 2022.
  • Average Operating Expenses over 5 years is $1.8 million, with a median of $1.9 million recorded in 2025.
  • Peak YoY movement for Operating Expenses: soared 111.67% in 2022, then fell 19.29% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $1.8 million in 2022, then decreased by 11.41% to $1.6 million in 2023, then increased by 26.25% to $2.0 million in 2024, then rose by 4.52% to $2.1 million in 2025, then dropped by 7.03% to $1.9 million in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Operating Expenses are $1.9 million (Q1 2026), $2.1 million (Q4 2025), and $1.9 million (Q3 2025).